183 related articles for article (PubMed ID: 24532042)
1. Anti-ADAMTS13 IgG autoantibodies present in healthy individuals share linear epitopes with those in patients with thrombotic thrombocytopenic purpura.
Grillberger R; Casina VC; Turecek PL; Zheng XL; Rottensteiner H; Scheiflinger F
Haematologica; 2014 Apr; 99(4):e58-60. PubMed ID: 24532042
[No Abstract] [Full Text] [Related]
2. Pathogenicity of Anti-ADAMTS13 Autoantibodies in Acquired Thrombotic Thrombocytopenic Purpura.
Thomas MR; de Groot R; Scully MA; Crawley JT
EBioMedicine; 2015 Aug; 2(8):942-52. PubMed ID: 26425702
[TBL] [Abstract][Full Text] [Related]
3. Multiple domains of ADAMTS13 are targeted by autoantibodies against ADAMTS13 in patients with acquired idiopathic thrombotic thrombocytopenic purpura.
Zheng XL; Wu HM; Shang D; Falls E; Skipwith CG; Cataland SR; Bennett CL; Kwaan HC
Haematologica; 2010 Sep; 95(9):1555-62. PubMed ID: 20378566
[TBL] [Abstract][Full Text] [Related]
4. Unraveling the immunologic response in thrombotic thrombocytopenic purpura.
Knöbl P
J Thromb Haemost; 2006 Nov; 4(11):2352-4. PubMed ID: 16938122
[No Abstract] [Full Text] [Related]
5. Persistence of circulating ADAMTS13-specific immune complexes in patients with acquired thrombotic thrombocytopenic purpura.
Ferrari S; Palavra K; Gruber B; Kremer Hovinga JA; Knöbl P; Caron C; Cromwell C; Aledort L; Plaimauer B; Turecek PL; Rottensteiner H; Scheiflinger F
Haematologica; 2014 Apr; 99(4):779-87. PubMed ID: 24241492
[TBL] [Abstract][Full Text] [Related]
6. Pathogenesis and treatment of acquired idiopathic thrombotic thrombocytopenic purpura.
Peyvandi F; Palla R; Lotta LA
Haematologica; 2010 Sep; 95(9):1444-7. PubMed ID: 20807984
[No Abstract] [Full Text] [Related]
7. Anti-ADAMTS13 Autoantibodies against Cryptic Epitopes in Immune-Mediated Thrombotic Thrombocytopenic Purpura.
Roose E; Vidarsson G; Kangro K; Verhagen OJHM; Mancini I; Desender L; Pareyn I; Vandeputte N; Vandenbulcke A; Vendramin C; Schelpe AS; Voorberg J; Azerad MA; Gilardin L; Scully M; Dierickx D; Deckmyn H; De Meyer SF; Peyvandi F; Vanhoorelbeke K
Thromb Haemost; 2018 Oct; 118(10):1729-1742. PubMed ID: 30235483
[TBL] [Abstract][Full Text] [Related]
8. Acquired thrombotic thrombocytopenic purpura: ADAMTS13 activity, anti-ADAMTS13 autoantibodies and risk of recurrent disease.
Lämmle B; Kremer Hovinga JA; George JN
Haematologica; 2008 Feb; 93(2):172-7. PubMed ID: 18245649
[No Abstract] [Full Text] [Related]
9. ADAMTS13 and anti-ADAMTS13 autoantibodies in thrombotic thrombocytopenic purpura - current perspectives and new treatment strategies.
Tersteeg C; Verhenne S; Roose E; Schelpe AS; Deckmyn H; De Meyer SF; Vanhoorelbeke K
Expert Rev Hematol; 2016; 9(2):209-21. PubMed ID: 26581428
[TBL] [Abstract][Full Text] [Related]
10. Multiple B-cell clones producing antibodies directed to the spacer and disintegrin/thrombospondin type-1 repeat 1 (TSP1) of ADAMTS13 in a patient with acquired thrombotic thrombocytopenic purpura.
Luken BM; Kaijen PH; Turenhout EA; Kremer Hovinga JA; van Mourik JA; Fijnheer R; Voorberg J
J Thromb Haemost; 2006 Nov; 4(11):2355-64. PubMed ID: 16898953
[TBL] [Abstract][Full Text] [Related]
11. Epitope analysis of autoantibodies to ADAMTS13 in patients with acquired thrombotic thrombocytopenic purpura.
Yamaguchi Y; Moriki T; Igari A; Nakagawa T; Wada H; Matsumoto M; Fujimura Y; Murata M
Thromb Res; 2011 Aug; 128(2):169-73. PubMed ID: 21496883
[TBL] [Abstract][Full Text] [Related]
12. Residues Arg568 and Phe592 contribute to an antigenic surface for anti-ADAMTS13 antibodies in the spacer domain.
Pos W; Sorvillo N; Fijnheer R; Feys HB; Kaijen PH; Vidarsson G; Voorberg J
Haematologica; 2011 Nov; 96(11):1670-7. PubMed ID: 21712537
[TBL] [Abstract][Full Text] [Related]
13. [anti-ADAMTS13 autoantibodies in patients with thrombotic thrombocytopenic purpura].
Matsumoto M
Nihon Rinsho Meneki Gakkai Kaishi; 2013; 36(2):95-103. PubMed ID: 23629429
[TBL] [Abstract][Full Text] [Related]
14. ADAMTS13-binding IgG are present in patients with thrombotic thrombocytopenic purpura.
Tsai HM; Raoufi M; Zhou W; Guinto E; Grafos N; Ranzurmal S; Greenfield RS; Rand JH
Thromb Haemost; 2006 May; 95(5):886-92. PubMed ID: 16676082
[TBL] [Abstract][Full Text] [Related]
15. IgG subclass distribution of anti-ADAMTS13 antibodies in patients with acquired thrombotic thrombocytopenic purpura.
Ferrari S; Mudde GC; Rieger M; Veyradier A; Kremer Hovinga JA; Scheiflinger F
J Thromb Haemost; 2009 Oct; 7(10):1703-10. PubMed ID: 19682238
[TBL] [Abstract][Full Text] [Related]
16. Thrombotic thrombocytopenic purpura associated with statin therapy.
Thomas MR; McDonald V; Machin SJ; Scully MA
Blood Coagul Fibrinolysis; 2011 Dec; 22(8):762-3. PubMed ID: 22198366
[No Abstract] [Full Text] [Related]
17. A 9-month-old infant with acquired idiopathic thrombotic thrombocytopenic purpura caused by inhibitory IgG-autoantibody to ADAMTS13.
Sato A; Hoshi Y; Onuma M; Sato R; Tsunematsu Y; Isonishi A; Matsumoto M; Fujimura Y; Imaizumi M
Pediatr Hematol Oncol; 2010 Feb; 27(1):53-8. PubMed ID: 20121555
[TBL] [Abstract][Full Text] [Related]
18. The spacer domain of ADAMTS13 contains a major binding site for antibodies in patients with thrombotic thrombocytopenic purpura.
Luken BM; Turenhout EA; Hulstein JJ; Van Mourik JA; Fijnheer R; Voorberg J
Thromb Haemost; 2005 Feb; 93(2):267-74. PubMed ID: 15711742
[TBL] [Abstract][Full Text] [Related]
19. Humoral immune response to ADAMTS13 in acquired thrombotic thrombocytopenic purpura.
Pos W; Luken BM; Sorvillo N; Kremer Hovinga JA; Voorberg J
J Thromb Haemost; 2011 Jul; 9(7):1285-91. PubMed ID: 21535387
[TBL] [Abstract][Full Text] [Related]
20. ADAMTS13 and anti-ADAMTS13 antibodies as markers for recurrence of acquired thrombotic thrombocytopenic purpura during remission.
Peyvandi F; Lavoretano S; Palla R; Feys HB; Vanhoorelbeke K; Battaglioli T; Valsecchi C; Canciani MT; Fabris F; Zver S; Réti M; Mikovic D; Karimi M; Giuffrida G; Laurenti L; Mannucci PM
Haematologica; 2008 Feb; 93(2):232-9. PubMed ID: 18223285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
